Recursion Pharmaceuticals
for the treatment of progressive neurofibromatosis type mutated | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
96 of 143
Similar slides by Recursion Pharmaceuticals
See diffirences between slides (animation)
Investor Day
January 2023
for the treatment of difficile infection | Recursion Pharmaceuticals
Investor Day
January 2023
for the treatment of solid tumors with mutant cancers | Recursion Pharmaceuticals
Investor Day
January 2023
for the treatment of familial adenomatous polyposis | Recursion Pharmaceuticals
Investor Day
January 2023
for the treatment of symptomatic cerebral cavernous malformations | Recursion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io